Rural New England Health Study (Phase 2)

NARecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Hepatitis COpioid Use DisorderIV Drug Usage
Interventions
OTHER

Mobile Tele-HCV Care

Study participants receive HCV care via telemedicine. Telemedicine appointments are performed on a mobile van.

OTHER

Enhanced Usual Care

Study participants are referred to a clinician in their area for HCV care.

Trial Locations (3)

03431

RECRUITING

Mobile Study Van, Keene

05201

RECRUITING

Mobile Study Van, Bennington

05301

RECRUITING

Mobile Study Van, Brattleboro

All Listed Sponsors
collaborator

Tufts University

OTHER

collaborator

University of New Hampshire

OTHER

collaborator

University of Vermont

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Better Life Partners Inc

UNKNOWN

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Baystate Medical Center

OTHER

NCT05466331 - Rural New England Health Study (Phase 2) | Biotech Hunter | Biotech Hunter